Vaxxinity Price Prediction

VAXXDelisted Stock  USD 2.72  0.19  6.53%   
At this time, The relative strength index (RSI) of Vaxxinity's share price is at 58. This entails that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Vaxxinity, making its price go up or down.

Oversold Vs Overbought

58

 
Oversold
 
Overbought
The successful prediction of Vaxxinity's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Vaxxinity, which may create opportunities for some arbitrage if properly timed.
Using Vaxxinity hype-based prediction, you can estimate the value of Vaxxinity from the perspective of Vaxxinity response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vaxxinity to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Vaxxinity because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Vaxxinity after-hype prediction price

    
  USD 2.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxxinity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
2.172.172.99
Details
Naive
Forecast
LowNextHigh
3.013.013.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.622.853.08
Details

Vaxxinity After-Hype Price Prediction Density Analysis

As far as predicting the price of Vaxxinity at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vaxxinity or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Vaxxinity, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Vaxxinity Estimiated After-Hype Price Volatility

In the context of predicting Vaxxinity's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vaxxinity's historical news coverage. Vaxxinity's after-hype downside and upside margins for the prediction period are 2.72 and 2.72, respectively. We have considered Vaxxinity's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.72
2.72
After-hype Price
2.72
Upside
Vaxxinity is very steady at this time. Analysis and calculation of next after-hype price of Vaxxinity is based on 3 months time horizon.

Vaxxinity Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Vaxxinity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaxxinity backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vaxxinity, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
19 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.72
2.72
0.00 
0.00  
Notes

Vaxxinity Hype Timeline

Vaxxinity is at this time traded for 2.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vaxxinity is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Vaxxinity is about 0.0%, with the expected price after the next announcement by competition of 2.72. About 51.0% of the company outstanding shares are owned by insiders. The book value of Vaxxinity was at this time reported as 0.11. The company has Price/Earnings To Growth (PEG) ratio of 0.05. Vaxxinity recorded a loss per share of 0.45. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be any time.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Vaxxinity Related Hype Analysis

Having access to credible news sources related to Vaxxinity's direct competition is more important than ever and may enhance your ability to predict Vaxxinity's future price movements. Getting to know how Vaxxinity's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vaxxinity may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TARSTarsus Pharmaceuticals 0.63 8 per month 1.78  0.27  6.32 (3.85) 16.85 
LIANLianBio ADR 0.00 0 per month 3.34  0.01  6.76 (5.00) 20.98 
ALDXAldeyra(0.15)5 per month 0.00 (0.04) 6.69 (5.26) 22.45 
TVTXTravere Therapeutics(0.30)10 per month 1.95  0.24  11.58 (4.13) 23.97 
ETONEton Pharmaceuticals 0.60 11 per month 1.79  0.39  7.56 (3.13) 21.89 
GPCRStructure Therapeutics American(0.25)8 per month 0.00 (0.08) 8.18 (6.07) 24.50 
IOBTIO Biotech 0.03 6 per month 0.00 (0.06) 9.92 (10.57) 69.64 
ERASErasca Inc(0.08)8 per month 3.53 (0.02) 7.34 (5.19) 17.38 
ASLNAslan Pharmaceuticals(0.12)8 per month 0.00 (0.26) 8.75 (18.91) 58.28 
LYRALyra Therapeutics(0.01)4 per month 0.00 (0.09) 10.53 (10.00) 41.07 
APLTApplied Therapeutics 0.03 9 per month 0.00 (0.04) 5.60 (9.72) 84.88 
STTKShattuck Labs(0.01)10 per month 0.00 (0.17) 6.93 (9.82) 51.03 
VINCVincerx Pharma(0.01)4 per month 0.00 (0.22) 6.06 (7.32) 47.76 
BCABBioatla 0.19 8 per month 4.78 (0.01) 12.86 (7.59) 31.41 
THRDThird Harmonic Bio(0.28)7 per month 4.79  0.02  8.35 (6.74) 25.76 
PASGPassage Bio(0.02)8 per month 5.91  0.1  12.07 (10.45) 32.24 
HOWLWerewolf Therapeutics(0.14)5 per month 4.52 (0.01) 8.54 (8.55) 49.02 
ACRVAcrivon Therapeutics, Common(0.60)5 per month 0.00 (0.08) 7.66 (7.65) 22.84 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.19) 6.21 (9.35) 34.87 
PEPGPepGen 0.39 8 per month 0.00 (0.21) 5.12 (9.02) 26.81 
TYRATyra Biosciences(2.41)10 per month 0.00 (0.09) 5.20 (6.06) 34.43 
CMPXCompass Therapeutics(0.15)4 per month 4.24  0.09  11.19 (5.92) 29.38 
VIGLVigil Neuroscience 0.01 5 per month 0.00 (0.10) 7.39 (7.22) 37.50 
PRTCPureTech Health PLC(1.48)2 per month 0.00 (0.05) 4.06 (5.57) 14.97 

Vaxxinity Additional Predictive Modules

Most predictive techniques to examine Vaxxinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vaxxinity using various technical indicators. When you analyze Vaxxinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Vaxxinity Predictive Indicators

The successful prediction of Vaxxinity stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vaxxinity, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vaxxinity based on analysis of Vaxxinity hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vaxxinity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vaxxinity's related companies.

Story Coverage note for Vaxxinity

The number of cover stories for Vaxxinity depends on current market conditions and Vaxxinity's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vaxxinity is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vaxxinity's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Vaxxinity Short Properties

Vaxxinity's future price predictability will typically decrease when Vaxxinity's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vaxxinity often depends not only on the future outlook of the potential Vaxxinity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaxxinity's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding126.5 M
Cash And Short Term Investments30.5 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Consideration for investing in Vaxxinity Pink Sheet

If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Transaction History
View history of all your transactions and understand their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities